Cargando…
A Comparative Study of the Anticancer Activity and PARP-1 Inhibiting Effect of Benzofuran–Pyrazole Scaffold and Its Nano-Sized Particles in Human Breast Cancer Cells
Breast cancer is considered the most common and deadly cancer among women worldwide. Nanomedicine has become extremely attractive in the field of cancer treatment. Due to the high surface to volume ratio and other unique properties, nanomaterials can be specifically targeted to certain cells and tis...
Autores principales: | Anwar, Manal M., Abd El-Karim, Somaia S., Mahmoud, Ahlam H., Amr, Abd El-Galil E., Al-Omar, Mohamed A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6650948/ https://www.ncbi.nlm.nih.gov/pubmed/31261939 http://dx.doi.org/10.3390/molecules24132413 |
Ejemplares similares
-
Development of a New Benzofuran–Pyrazole–Pyridine-Based Molecule for the Management of Osteoarthritis
por: Abd El-Karim, Somaia S., et al.
Publicado: (2023) -
Kinase Inhibitory Activities and Molecular Docking of a Novel Series of Anticancer Pyrazole Derivatives
por: Nossier, Eman S., et al.
Publicado: (2018) -
New Quinoxaline-Based Derivatives as PARP-1 Inhibitors: Design, Synthesis, Antiproliferative, and Computational Studies
por: Syam, Yasmin M., et al.
Publicado: (2022) -
Synthesis and 2D-QSAR Study of Active Benzofuran-Based Vasodilators
por: Khalifa, Nagy M., et al.
Publicado: (2017) -
Anticancer therapeutic potential of benzofuran scaffolds
por: Abbas, Ashraf A., et al.
Publicado: (2023)